Global Artificial Pulmonary Valve System Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Artificial Pulmonary Valve System market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Artificial Pulmonary Valve System include Edwards Lifesciences, Epicor Medical, Terumo, Valtech Cardio, Boston Scientific, Venus Medtech Medical Device, Medtronic and Abbott, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artificial Pulmonary Valve System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pulmonary Valve System.
The Artificial Pulmonary Valve System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Pulmonary Valve System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Artificial Pulmonary Valve System Segment by Company

Edwards Lifesciences
Epicor Medical
Terumo
Valtech Cardio
Boston Scientific
Venus Medtech Medical Device
Medtronic
Abbott
Artificial Pulmonary Valve System Segment by Type

PLA
PCL
Others
Artificial Pulmonary Valve System Segment by Application

Pulmonary Valve Regurgitation
Pulmonary Valve Stenosis
Pulmonary Hypertension
Others
Artificial Pulmonary Valve System Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pulmonary Valve System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pulmonary Valve System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pulmonary Valve System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Pulmonary Valve System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Artificial Pulmonary Valve System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Artificial Pulmonary Valve System Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Artificial Pulmonary Valve System Sales Estimates and Forecasts (2020-2031)
1.3 Artificial Pulmonary Valve System Market by Type
1.3.1 PLA
1.3.2 PCL
1.3.3 Others
1.4 Global Artificial Pulmonary Valve System Market Size by Type
1.4.1 Global Artificial Pulmonary Valve System Market Size Overview by Type (2020-2031)
1.4.2 Global Artificial Pulmonary Valve System Historic Market Size Review by Type (2020-2025)
1.4.3 Global Artificial Pulmonary Valve System Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Artificial Pulmonary Valve System Sales Breakdown by Type (2020-2025)
1.5.2 Europe Artificial Pulmonary Valve System Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Artificial Pulmonary Valve System Sales Breakdown by Type (2020-2025)
1.5.4 South America Artificial Pulmonary Valve System Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Artificial Pulmonary Valve System Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Artificial Pulmonary Valve System Industry Trends
2.2 Artificial Pulmonary Valve System Industry Drivers
2.3 Artificial Pulmonary Valve System Industry Opportunities and Challenges
2.4 Artificial Pulmonary Valve System Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Artificial Pulmonary Valve System Revenue (2020-2025)
3.2 Global Top Players by Artificial Pulmonary Valve System Sales (2020-2025)
3.3 Global Top Players by Artificial Pulmonary Valve System Price (2020-2025)
3.4 Global Artificial Pulmonary Valve System Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Artificial Pulmonary Valve System Major Company Production Sites & Headquarters
3.6 Global Artificial Pulmonary Valve System Company, Product Type & Application
3.7 Global Artificial Pulmonary Valve System Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Artificial Pulmonary Valve System Market CR5 and HHI
3.8.2 Global Top 5 and 10 Artificial Pulmonary Valve System Players Market Share by Revenue in 2024
3.8.3 2023 Artificial Pulmonary Valve System Tier 1, Tier 2, and Tier 3
4 Artificial Pulmonary Valve System Regional Status and Outlook
4.1 Global Artificial Pulmonary Valve System Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Artificial Pulmonary Valve System Historic Market Size by Region
4.2.1 Global Artificial Pulmonary Valve System Sales in Volume by Region (2020-2025)
4.2.2 Global Artificial Pulmonary Valve System Sales in Value by Region (2020-2025)
4.2.3 Global Artificial Pulmonary Valve System Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Artificial Pulmonary Valve System Forecasted Market Size by Region
4.3.1 Global Artificial Pulmonary Valve System Sales in Volume by Region (2026-2031)
4.3.2 Global Artificial Pulmonary Valve System Sales in Value by Region (2026-2031)
4.3.3 Global Artificial Pulmonary Valve System Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Artificial Pulmonary Valve System by Application
5.1 Artificial Pulmonary Valve System Market by Application
5.1.1 Pulmonary Valve Regurgitation
5.1.2 Pulmonary Valve Stenosis
5.1.3 Pulmonary Hypertension
5.1.4 Others
5.2 Global Artificial Pulmonary Valve System Market Size by Application
5.2.1 Global Artificial Pulmonary Valve System Market Size Overview by Application (2020-2031)
5.2.2 Global Artificial Pulmonary Valve System Historic Market Size Review by Application (2020-2025)
5.2.3 Global Artificial Pulmonary Valve System Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Artificial Pulmonary Valve System Sales Breakdown by Application (2020-2025)
5.3.2 Europe Artificial Pulmonary Valve System Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Artificial Pulmonary Valve System Sales Breakdown by Application (2020-2025)
5.3.4 South America Artificial Pulmonary Valve System Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Artificial Pulmonary Valve System Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Edwards Lifesciences
6.1.1 Edwards Lifesciences Comapny Information
6.1.2 Edwards Lifesciences Business Overview
6.1.3 Edwards Lifesciences Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Edwards Lifesciences Artificial Pulmonary Valve System Product Portfolio
6.1.5 Edwards Lifesciences Recent Developments
6.2 Epicor Medical
6.2.1 Epicor Medical Comapny Information
6.2.2 Epicor Medical Business Overview
6.2.3 Epicor Medical Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Epicor Medical Artificial Pulmonary Valve System Product Portfolio
6.2.5 Epicor Medical Recent Developments
6.3 Terumo
6.3.1 Terumo Comapny Information
6.3.2 Terumo Business Overview
6.3.3 Terumo Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Terumo Artificial Pulmonary Valve System Product Portfolio
6.3.5 Terumo Recent Developments
6.4 Valtech Cardio
6.4.1 Valtech Cardio Comapny Information
6.4.2 Valtech Cardio Business Overview
6.4.3 Valtech Cardio Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Valtech Cardio Artificial Pulmonary Valve System Product Portfolio
6.4.5 Valtech Cardio Recent Developments
6.5 Boston Scientific
6.5.1 Boston Scientific Comapny Information
6.5.2 Boston Scientific Business Overview
6.5.3 Boston Scientific Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boston Scientific Artificial Pulmonary Valve System Product Portfolio
6.5.5 Boston Scientific Recent Developments
6.6 Venus Medtech Medical Device
6.6.1 Venus Medtech Medical Device Comapny Information
6.6.2 Venus Medtech Medical Device Business Overview
6.6.3 Venus Medtech Medical Device Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Venus Medtech Medical Device Artificial Pulmonary Valve System Product Portfolio
6.6.5 Venus Medtech Medical Device Recent Developments
6.7 Medtronic
6.7.1 Medtronic Comapny Information
6.7.2 Medtronic Business Overview
6.7.3 Medtronic Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Medtronic Artificial Pulmonary Valve System Product Portfolio
6.7.5 Medtronic Recent Developments
6.8 Abbott
6.8.1 Abbott Comapny Information
6.8.2 Abbott Business Overview
6.8.3 Abbott Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Abbott Artificial Pulmonary Valve System Product Portfolio
6.8.5 Abbott Recent Developments
7 North America by Country
7.1 North America Artificial Pulmonary Valve System Sales by Country
7.1.1 North America Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Artificial Pulmonary Valve System Sales by Country (2020-2025)
7.1.3 North America Artificial Pulmonary Valve System Sales Forecast by Country (2026-2031)
7.2 North America Artificial Pulmonary Valve System Market Size by Country
7.2.1 North America Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Artificial Pulmonary Valve System Market Size by Country (2020-2025)
7.2.3 North America Artificial Pulmonary Valve System Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Artificial Pulmonary Valve System Sales by Country
8.1.1 Europe Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Artificial Pulmonary Valve System Sales by Country (2020-2025)
8.1.3 Europe Artificial Pulmonary Valve System Sales Forecast by Country (2026-2031)
8.2 Europe Artificial Pulmonary Valve System Market Size by Country
8.2.1 Europe Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Artificial Pulmonary Valve System Market Size by Country (2020-2025)
8.2.3 Europe Artificial Pulmonary Valve System Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Artificial Pulmonary Valve System Sales by Country
9.1.1 Asia-Pacific Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Artificial Pulmonary Valve System Sales by Country (2020-2025)
9.1.3 Asia-Pacific Artificial Pulmonary Valve System Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Artificial Pulmonary Valve System Market Size by Country
9.2.1 Asia-Pacific Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Artificial Pulmonary Valve System Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Artificial Pulmonary Valve System Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Artificial Pulmonary Valve System Sales by Country
10.1.1 South America Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Artificial Pulmonary Valve System Sales by Country (2020-2025)
10.1.3 South America Artificial Pulmonary Valve System Sales Forecast by Country (2026-2031)
10.2 South America Artificial Pulmonary Valve System Market Size by Country
10.2.1 South America Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Artificial Pulmonary Valve System Market Size by Country (2020-2025)
10.2.3 South America Artificial Pulmonary Valve System Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Artificial Pulmonary Valve System Sales by Country
11.1.1 Middle East and Africa Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Artificial Pulmonary Valve System Sales by Country (2020-2025)
11.1.3 Middle East and Africa Artificial Pulmonary Valve System Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Artificial Pulmonary Valve System Market Size by Country
11.2.1 Middle East and Africa Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Artificial Pulmonary Valve System Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Artificial Pulmonary Valve System Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Artificial Pulmonary Valve System Value Chain Analysis
12.1.1 Artificial Pulmonary Valve System Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Artificial Pulmonary Valve System Production Mode & Process
12.2 Artificial Pulmonary Valve System Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Artificial Pulmonary Valve System Distributors
12.2.3 Artificial Pulmonary Valve System Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings